MyndTec Inc.

Recent News

MyndTec Brain Activity Technology Licensed from UHN Awarded U.S. Patent
Mississauga, Ontario--(Newsfile Corp. - April 9, 2024) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging player in neurological treatment and rehabilitation, today announced that the U.S. Patent and Trademark Office has granted U.S. Patent No. 11,955,217, to which MyndTec holds exclusive rights from the University Health Network ("UHN"). The granted patent is directed generally at technology used for the treatment of neural structural damage caused by certain diseases of the central nervous system and for controlling user...
2024-04-09 9:10 AM EDT
MyndTec Inc. Completes Fourth Tranche of Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - March 19, 2024) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging player in neurological treatment and rehabilitation, is pleased to announce that it has closed today the fourth tranche of its non-brokered private placement previously announced on October 13, 2023 (the "Offering"). The fourth tranche of the private placement consists of 180,214 Units of the Company (the "Units") at a price of $0.75 per Unit for aggregate gross proceeds to the Company of...
2024-03-19 7:00 PM EDT
MyndTec Inc. Completes Third Tranche of Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - February 13, 2024) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging player in neurological treatment and rehabilitation, is pleased to announce that it has closed today the third tranche of its non-brokered private placement previously announced on October 13, 2023 (the "Offering"). The third tranche consists of 179,080 Units of the Company (the "Units") at a price of $0.75 per Unit for aggregate gross proceeds to the Company of $134,310 (the "Third Tranche")....
2024-02-13 7:00 PM EST
MyndTec Inc. Receives Statement of Claim and Intends to Defend Itself
Mississauga, Ontario--(Newsfile Corp. - January 22, 2024) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a medical technology company, today announced it has been served with a statement of claim by Norton Rose Fulbright Canada LLP (NRFC). NRFC's claim is for damages for alleged breach of contract in the amount of $715,201.61 and interest, costs and taxes and relates to fees that it claims are owed for its legal services to the Company in relation to a previous private...
2024-01-22 5:45 PM EST
MyndTec Inc. Completes Second Tranche of Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - December 20, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in neurological treatment and rehabilitation, is pleased to announce that it has closed today the second tranche of its non-brokered private placement previously announced on October 13, 2023 (the "Offering"). The second tranche consists of 177,425 Units of the Company (the "Units") at a price of $0.75 per Unit for aggregate gross proceeds to the Company of $133,068.75 (the "Second Tranche")....
2023-12-20 7:00 PM EST
MyndTec Inc. Completes Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - November 3, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in neurological treatment and rehabilitation, is pleased to announce that it has closed today its previously announced non-brokered private placement of 184,280 units of the Company (the "Units") at a price of $0.75 per Unit for aggregate gross proceeds to the Company of $138,210.00 (the "Offering").Each Unit is comprised of one common share (each, a "Common Share") in the capital of...
2023-11-03 7:00 PM EDT
MyndTec Inc. Announces Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - October 13, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in neurological treatment and rehabilitation, is pleased to announce that it has launched a non-brokered private placement of up to 1,333,333 units of the Company (the "Units") at a price of $0.75 per Unit (the "Issue Price") to raise aggregate gross proceeds to the Company of up to $1,000,000 (the "Offering").Each Unit shall be comprised of one common share (each, a...
2023-10-13 7:00 PM EDT
MyndTec Inc. Announces Debt Settlement Agreement with a Director
Mississauga, Ontario--(Newsfile Corp. - August 17, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging force in neurological treatment and rehabilitation, is pleased to announce that it has entered into a debt settlement agreement (the "Debt Settlement Agreement") as of August 11, 2023 with Dr. Milos Popovic, a Director of MyndTec and formerly an interim Chief Executive Officer (CEO) to settle an outstanding debt in the amount of $75,000 (hereinafter the "Obligation"). The Debt comprises the...
2023-08-17 7:00 PM EDT
MyndTec Inc. Closes Previously Announced Shares for Debt Transaction
Mississauga, Ontario--(Newsfile Corp. - July 13, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging force in neurological treatment and rehabilitation, is pleased to announce that further to its news release dated July 6, 2023, it has issued 540,088 common shares in the capital of the Company (the "Common Shares") at a price of $0.70 per share to an arm's length creditor (the "Creditor") in settlement of $378,061.60 worth of debt owed by the Company to the Creditor...
2023-07-13 7:00 PM EDT
MyndTec Inc. Announces Debt Settlement Agreement
Mississauga, Ontario--(Newsfile Corp. - July 6, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging force in neurological treatment and rehabilitation, is pleased to announce that it has entered into a debt settlement agreement (the "Debt Settlement Agreement") as of May 29, 2023, with an arm's length creditor (the "Creditor") to settle an outstanding debt in the amount of $756,120.56 (the "Debt") (the "Transaction"). The Debt comprises the outstanding balance owed by the Company under...
2023-07-06 7:00 PM EDT

MyndTec Inc.

Recent News

Get News by Email

Stock Quote

RSS Feeds

Tell Us Your Story

Cookie Settings

Get News by Email

Stock Quote

RSS Feeds

Tell Us Your Story